• Publications
  • Influence
NC-531 (Neurochem).
  • Hugo Geerts
  • Medicine
    Current opinion in investigational drugs
  • 2004
NC-531 is a sulfated glycosaminoglycan mimetic that inhibits amyloid plaque formation, and is under development by Neurochem for the potential treatment of Alzheimer's disease. Phase I clinical